Literature DB >> 20740354

Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: report of a case.

Ayami Ohno1, Akira Mori, Ryuichiro Doi, Yoshikuni Yonenaga, Noboru Asano, Shinji Uemoto.   

Abstract

Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like syndrome (MELAS) is a rare, fetal disease caused by a mutation in mitochondrial DNA that leads to impaired oxidative metabolism in skeletal muscle, the central nervous system, and liver function. This report presents the case of a 50-year-old woman with biliary cystadenocarcinoma complicated by MELAS who underwent a successful left hemihepatectomy. In this case, the diagnostic key for the malignant tumor was an (18)F-fluorodeoxyglucose positron emission tomography study, which was useful even in a patient with MELAS, which causes abnormal glucose metabolism. The perioperative management of such patients includes special precautions to prevent lactic acidosis and deterioration of the reserved liver function after a hepatectomy, since the mitochondrial function in MELAS patients is abnormal. The patient in this report has remained free of liver dysfunctions and cancer recurrence for 2 years following the hepatectomy. This is the first report of a successful major hepatectomy for a patient with MELAS.

Entities:  

Mesh:

Year:  2010        PMID: 20740354     DOI: 10.1007/s00595-009-4145-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

Review 1.  Diagnosis and management of MELAS.

Authors:  Madhav Thambisetty; Nancy J Newman
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

Authors:  T Higashi; N Tamaki; T Honda; T Torizuka; T Kimura; T Inokuma; G Ohshio; R Hosotani; M Imamura; J Konishi
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

Review 4.  Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  S Mita; M Tokunaga; T Kumamoto; M Uchino; I Nonaka; M Ando
Journal:  Muscle Nerve Suppl       Date:  1995

5.  Population prevalence of the MELAS A3243G mutation.

Authors:  Neil Manwaring; Michael M Jones; Jie Jin Wang; Elena Rochtchina; Chris Howard; Paul Mitchell; Carolyn M Sue
Journal:  Mitochondrion       Date:  2007-01-08       Impact factor: 4.160

Review 6.  Biliary cystadenocarcinoma of the liver: the need for complete resection.

Authors:  J M Läuffer; H U Baer; C A Maurer; C Stoupis; A Zimmerman; M W Büchler
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

Review 7.  Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.

Authors:  Douglas M Sproule; Petra Kaufmann
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy.

Authors:  Nobuko Sasano; Yoshihito Fujita; Minhye So; Kazuya Sobue; Hiroshi Sasano; Hirotada Katsuya
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

9.  FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

Authors:  T Higashi; N Tamaki; T Torizuka; Y Nakamoto; H Sakahara; T Kimura; T Honda; T Inokuma; S Katsushima; G Ohshio; M Imamura; J Konishi
Journal:  J Nucl Med       Date:  1998-10       Impact factor: 10.057

10.  Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura-Yokoe; Katsuhiko Uesaka
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

View more
  4 in total

1.  Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome.

Authors:  Giorgina Barbara Piccoli; Laura Davico Bonino; Paola Campisi; Federica Neve Vigotti; Martina Ferraresi; Federica Fassio; Isabelle Brocheriou; Francesco Porpiglia; Gabriella Restagno
Journal:  BMC Nephrol       Date:  2012-02-21       Impact factor: 2.388

2.  Mitochondrial dysfunction and risk of cancer.

Authors:  M Lund; M Melbye; L J Diaz; M Duno; J Wohlfahrt; J Vissing
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

3.  Increased prevalence of malignancy in adult mitochondrial disorders.

Authors:  J Finsterer; E Krexner
Journal:  J Med Life       Date:  2013-12-25

Review 4.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.